Perioperative pain treatment
Conditions
Interventions
R:Monitoring of NOL with Maygreen Bispro was used to modulate the infusion of the dose used in remifentani
M:Monitoring of NOL with Maygreen Bispro was used to modulate the infusion of the dose used in remifentani
Sponsors
Second Xiangya Hospital of CSU
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.From September 1, 2024 to November 1, 2024, 84 patients undergoing total knee arthroplasty at Xiangya Second Hospital were included in the study. 2.Age>=18 years old; 3.ASA I~II; 4.BMI 18~27.9 kg/m^2;
Exclusion criteria
Exclusion criteria: 1.Minors (< 18 years old); 2.Patients who have been using opioid analgesics, ß-blockers, anticonvulsants or antiepileptic drugs for a long time; 3.patients who are allergic to the test drug; 4.Patients with frontal facial skin damage or inability to undergo EEG monitoring for other reasons; 5.emergency surgery; 6.Those who are unable to cooperate with the completion of VAS score measurement;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| incidence of VAS scores >= 5; | — |
Secondary
| Measure | Time frame |
|---|---|
| Continuous doses of remifentanil and propofol;VAS score;Probability of nausea and vomiting in the patient;Total length of hospital stay;Quality of Recovery-15; | — |
Countries
China
Contacts
Public ContactDonglin Yang
Second Xiangya Hospital of CSU
Outcome results
None listed